ArticleOncoimmunology2015

Reciprocal control of miR-197 and IL-6/STAT3 pathway reveals miR-197 as potential therapeutic target for hepatocellular carcinoma.

Huamin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.